Identification of novel LFNG mutations in spondylocostal dysostosis

J Hum Genet. 2019 Mar;64(3):261-264. doi: 10.1038/s10038-018-0548-2. Epub 2018 Dec 10.

Abstract

Spondylocostal dysostosis (SCDO) is a heterogeneous group of skeletal disorders characterized by multiple segmentation defects involving vertebrae and ribs. Seven disease genes have been reported as causal genes for SCDO: DLL3, MESP2, TBX6, HES7, RIPPLY2, DMRT2, and LFNG. Here we report a Japanese SCDO case with multiple severe vertebral anomalies from cervical to sacral spine. The patient was a compound heterozygote for c.372delG (p.K124Nfs*) and c.601G>A (p.D201N) variants of LFNG, which encodes a glycosyltransferase (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase). The missense variant was in the DxD motif, an active-site motif of the glycosyltransferase, and its loss of the enzyme function was confirmed by an in vitro enzyme assay. This is the second report of LFNG mutations in SCDO.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple / genetics*
  • Abnormalities, Multiple / pathology
  • Amino Acid Sequence
  • Glucosyltransferases
  • Glycosyltransferases / genetics*
  • Hernia, Diaphragmatic / genetics*
  • Hernia, Diaphragmatic / pathology
  • Hexosyltransferases / genetics*
  • Humans
  • Infant
  • Intracellular Signaling Peptides and Proteins / genetics*
  • Male
  • Membrane Proteins / genetics*
  • Mutation*
  • Prognosis
  • Sequence Homology

Substances

  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Glycosyltransferases
  • Glucosyltransferases
  • Hexosyltransferases
  • LFNG protein, human
  • MFNG protein, human

Supplementary concepts

  • Jarcho-Levin syndrome